IVIG Treatment for Refractory Immune-Related Adult Epilepsy.
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2014
At a glance
- Drugs Immune globulin (Primary)
- Indications Epilepsy; Partial epilepsies
- Focus Therapeutic Use
- Sponsors Baxter Healthcare Corporation
- 22 Jan 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 13 Mar 2012 New trial record